Assessment of Patterns of Potentially Unsafe Use of Zolpidem

JAMA Intern Med. 2018 Sep 1;178(9):1275-1277. doi: 10.1001/jamainternmed.2018.3031.

Authors

Thomas J Moore^{1

2}, Donald R Mattison³

Affiliations

¹ Institute for Safe Medication Practices, Alexandria, Virginia.
² Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, Washington, DC.
³ Risk Sciences International, Ottawa, Ontario, Canada.

Abstract

This study evaluates data from the US Medical Expenditure Panel Survey to determine the extent of unsafe use of zolpidem.

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Depression / drug therapy*
Dose-Response Relationship, Drug
Drug-Related Side Effects and Adverse Reactions / epidemiology*
Female
GABA-A Receptor Agonists / administration & dosage
GABA-A Receptor Agonists / adverse effects
Humans
Incidence
Male
Middle Aged
Risk Assessment / methods*
United States / epidemiology
Young Adult
Zolpidem / administration & dosage
Zolpidem / adverse effects*

Substances

GABA-A Receptor Agonists
Zolpidem